SPECTRAL THERAPEUTICS, INC.

Biotech · Private

Optical-encoded combinatorial library synthesis and screening platform for molecular discovery

Grants
$627K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Production of Stimulated Emission-Encoded Beads for Large Molecular Library Generation$322,388
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A Faster, Cheaper Way to Discover New Drugs: Using Tiny Laser Barcodes to Test Millions of Compounds$304,950
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2875PROMILEAD, LLC——
2876LIBREDE——
2877DELINEATE INC——
2878SPECTRAL THERAPEUTICS, INC.——
2879CYPRESS BIOPHARMA, INC.——
2880Sophia Bioscience Inc——
2881CG Oncology——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Composite Particles For Use In Generating Spectrally Encoded Libraries Of Chemical Compounds, And Methods Of Making And Using The Sameapplication
  • Composite Particles For Use In Generating Spectrally Encoded Libraries Of Chemical Compounds, And Methods Of Making And Using The Sameapplication
  • Composite Particles For Use In Generating Spectrally Encoded Libraries Of Chemical Compounds, And Methods Of Making And Using The Sameapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.